Nectin Therapeutics is a biotech company focused on unlocking the power of the immune system. We are developing a collection of next-generation immunotherapy agents.
Despite the unprecedented efficacy of existing immunotherapy agents, many patients either fail to respond, or following encouraging initial response, develop resistance over time. At Nectin, we have discovered novel resistance mechanisms and developed novel agents targeting these mechanisms for improved therapy.
At Nectin, we are dedicated to the development of novel therapeutic options for cancer patients. We are developing a diverse pipeline of targeted antibodies based on the nectin pathways. These antibodies overcome inhibitory pathways deployed by the tumors and allow immune cells to effectively destroy cancer cells. Additionally, based on the unique expression patterns of several nectin proteins, we develop CAR-T and -NK drivers that directly target tumor cells in various indications, including hard-to-treat cancers.
Company Details
- Employees
- 12
- Founded
- -
- Address
- Hi-Tech Campus, Givat Ram Campus,israel
- Industry
- Biotechnology
- Website
- http://www.nectintx.com
- HQ
- Jerusalem
Nectin Therapeutics Questions
Nectin Therapeutics's website is http://www.nectintx.com
Nectin Therapeutics's LinkedIn profile is https://il.linkedin.com/company/nectin-therapeutics
Nectin Therapeutics has
12 employees.
View email and phone details for 12
employees at Nectin Therapeutics.
Nectin Therapeutics's industry is
Biotechnology
Nectin Therapeutics's top competitors are
Splisense,
Pepticom Ltd.,
Tissue Dynamics,
Protai,
Aummune,
Vivox - Experts In Vivo,
Cavos Biotherapeutics,
Kahr-Medical Ltd.,
Cytoreason,
Biogiv.
Nectin Therapeutics's categories are Biotechnology
Nectin Therapeutics's founding year is 2017
